Icon

BRUKINSA (nda213217)- (80MG)

ZANUBRUTINIB BEIGENE
80MG
Yes No
2043-Jan-19 2024-Nov-14
None None
None No
BRUKINSA is a kinase inhibitor indicated for the treatment of adult patients with:  Mantle cell lymphoma (MCL) who have received at least one prior therapy.  Waldenström’s macroglobulinemia (WM).  Relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen.
0 0 0
Total Other Developers 4
Drugs with Suitability No
80MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.